Article

In the know: Toyota helps visually impaired go places

A roundup of ophthalmic news from early March 2016.

David Pyott

1. AAO receives largest gift in history

David Pyott, ex-Allergan chief executive officer, donated $2 million to the American Academy of Ophthalmology (AAO) to develop a new glaucoma education resource. This endowment was the largest gift ever contributed to the academy’s foundation from a single individual. 

 

2. Cooper Cos. revenues increase to almost $450 million

President and Chief Executive Officer, Robert S. Weiss, said in a statement that he attributes some of the company growth to its Biofinity line and 1-day silicone hydrogel products.

 

Victor Curtin, MD

3. Renowned ophthalmologist and professor Victor Curtin, MD, passes away

Victor T. Curtin, MD, an emeritus professor of ophthalmology for 57 years at Bascom Palmer Eye Institute, passed away March 9, 2016 in Miami. Dr. Curtin completed his fellowship in ocular pathology and retinal disease at Massachusetts Eye and Ear Infirmary and a fellowship in ophthalmic pathology at the National Institutes of Health and the Armed Forces Institute of Pathology.

 

Stephen From

4. EyeGate Pharma acquires Jade Therapeutics

With the acquisition, EyeGate will now have pre-clinical projects as well as Jade’s proprietary, cross-linked, bio-erodible hydrogel technology. “Our expanded pipeline now includes both preclinical and clinical assets that collectively address a large market opportunity,” said Stephen From, EyeGate chief executive officer.

 

Courtesy of Toyota

5. Toyota Project BLAID helps visually impaired people gain mobility

To help all people enjoy better mobility and freedom, Toyota is developing a wearable device to help visually impaired people better navigate indoors. The project is still in its early stages.

 

6. Visunex receives FDA clearance on PanoCam Pro

The PanoCam Pro will be able to detect external, anterior, and posterior segment vision disorders in newborns. The developers hope this device will help millions of children every year.

Related: Imaging device for newborns may prompt universal vision screening

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.